Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
8
×
clinical trials
life sciences
national blog main
biotech
fda
boston blog main
eli lilly
national top stories
new york blog main
boston top stories
indiana blog main
indiana top stories
new york top stories
national
raleigh-durham blog main
raleigh-durham top stories
teva pharmaceutical
allergan
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
chronic migraine
detroit blog main
detroit top stories
migraine
migraine research foundation
novartis
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
alnylam pharmaceuticals
What
fda
8
×
drug
new
medicines
migraine
won
approval
class
approved
cholesterol
decades
developed
drugs
eli
lilly
medco
nod
pain
starts
acquire
acute
addresses
adults
agreed
allergan
amgen
announced
arguments
august
big
billion
bio
biotech
bringing
brings
busy
candidates
cash
causes
clears
Language
unset
Current search:
amgen
×
fda
×
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines